Isabella Bon
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia.
Journal: Journal of medical microbiology
Published: April 10, 2026
Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing.
Journal: The Journal of antimicrobial chemotherapy
Published: September 18, 2025
Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level Viremia.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: March 03, 2024
Improvement in insulin sensitivity after switching from an integrase inhibitor-based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
Journal: HIV medicine
Published: January 25, 2024
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experience.
Journal: International journal of STD & AIDS
Published: August 11, 2023
Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed People Living with HIV-1 Aged Over 65 Years.
Journal: AIDS research and human retroviruses
Published: June 19, 2023
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Tenofovir Alafenamide/Emtricitabine/Bictegravir.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 18, 2022
Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir.
Journal: AIDS (London, England)
Published: December 07, 2021
Changes in Serum Inflammatory Markers in Antiretroviral Therapy-Naive HIV-Infected Patients Starting Dolutegravir/Lamivudine or Dolutegravir/Lamivudine/Abacavir.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: November 07, 2021
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy.
Journal: Scientific reports
Published: August 26, 2021
Restriction Factors expression decreases in HIV-1 patients after cART.
Journal: The new microbiologica
Published: May 12, 2021
Last Updated: 09/26/2026